Human Technopole continues its dialogue with Italian Research Hospitals (IRCCS).
16 January 2020
Human Technopole continues its dialogue with Italian Research Hospitals (IRCCS).
Milan, 15 January – Human Technopole is an open hub for the entire Italian scientific community. This is how Marco Simoni – President of Human Technopole – described the Foundation during the event “Le strategie di ricerca della Fondazione Human Technopole: quali opportunità per gli IRCCS della Lombardia“, held at Palazzo Italia and organized by Assolombarda.
President Marco Simoni, Maria Grazia Magro (Head of Strategy and Scientific Affairs of Human Technopole) and Giuseppe Testa (Head of Neurogenomics Centre) explained the next steps of Human Technopole to almost 40 Research Hospitals’ General Director and Scientific Directors including Maria Chiara Carrozza (Scientific Director of Fondazione Don Gnocchi ), Alberto Mantovani (Scientific Director of Humanitas) and Fabrizio Tagliavini (Scientific Director of the Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta). Sergio Dompé – Vice President Life Sciences, Assolombarda – underlined Human Technopole’s innovative scope, its impact on Lombardy’s economic income and expressed the strong contribution that Assolombarda wants to give to the IRCCSs of Lombardy.
Human Technopole’s openness, its positive effects for the whole country and common objectives with the IRCCSs are the concepts stressed in Marco Simoni’s speech; Maria Grazia Magro highlighted the dialogue carried out with the representatives of the Italian scientific community in the past months when more than half of the Italian IRCCSs were met individually by Human Technopole. Giuseppe Testa focused on the work of his centre and on the synergies that can be implemented with the scientific community in the near future.
Yesterday, Open HT was announced – the first event organized by Human Technopole addressed to the scientific community, which will be the first, shared occasion of systematic dialogue on the Foundation’s development strategies.
An international study coordinated by Milan’s Human Technopole, the Institute of Cancer Research (ICR) in London, and the Royal Marsden Hospital in London has shown that certain DNA fragments found in the blood of paediatric cancer patients can be used as “biomarkers” to obtain information on the characteristics of the disease and its ability to resist therapies. Analysing these fragments could represent an effective alternative to tumour tissue biopsy, a practice that is particularly difficult in children.
Human Technopole is honoured to have participated in today’s meeting at the Quirinale, where President of the Republic Sergio Mattarella welcomed a delegation from MIND on the occasion of the tenth anniversary of the universal exposition Milano EXPO 2015.
Meet Carlos Jimenez, Postdoc in the Bienko Group (Genomics), who has been awarded a prestigious Marie Skłodowska-Curie Actions Postdoctoral Fellowship from the European Union. The grant, totalling €172,750.08 and covering a two-year period, will support his groundbreaking project PRUNE – Uncovering the Proteomic Radial Organisation within the Eukaryotic Nucleus – to study how the spatial arrangement of nuclear proteins contributes to optimal cell functioning.
By developing a sophisticated in vitro system coupled with advanced imaging techniques and CRISPR genome editing, an international team of researchers from Human Technopole (Italy) and the TUD Dresden University of Technology (Germany) shows that tubulin tyrosination/detyrosination regulates the bidirectional IFT train movement and avoids collision between trains moving in opposite directions along the cilium. The research was funded by the ERC and the DFG “Physics of Life” Excellence Cluster. The results are published in Nature Communications.
The public notice for the creation of a list of lawyers, from which legal representation assignments may be drawn in the interest of the Human Technopole Foundation, is now online.
Manage Cookie Consent
This website uses technical cookies to provide you with a better browsing experience and, subject to your consent, profiling cookies to offer you information and advertising in line with your preferences. For more details, you can consult our cookie policy by clicking on the link below, or set your preferences by clicking "set preferences". By selecting "accept cookies" you consent to the use of all types of cookies while you can revoke your consent by clicking on "refuse". By deciding to refuse or closing the banner, only the technical cookies necessary for the correct functioning of the site will be activated.
Technical cookies (required)
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Third party cookies for statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Third party cookies for profiling
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.